Background: Cystic echinococcosis, caused by the cestode Echinococcus granulosus, is a neglected tropical disease with remarkable morbidity in humans and a problem of worldwide economic importance in livestock industry. Understanding the molecular basis of the parasite growth and development is essential for the disease diagnosis, management and control. The tetraspanin (TSP) family of proteins are transmembrane proteins with a role in many physiological processes of eukaryotic organisms. TSPs present in the tegumental surface of platyhelminths play pivotal roles in host-parasite interaction. However, little is known about the role of TSPs in growth and development in the Platyhelminthes. To understand the role of TSP1 in the growth and development of E. granulosus we investigated the effect of EgTSP1-specific long dsRNA in different in vitro stages of the parasite. Methods: Different stages of E. granulosus, protoscoleces and strobilated worms, were cultivated In vitro in di-phasic media. Using long dsRNA and two delivery methods, i.e. electroporation and electro-soaking, EgTSP1 silencing was performed with an EgTSP1-specific dsRNA. The TSP1 expression profile was assessed as well as the biological and ultrastructural properties of the parasites. Results: After three days of dsRNA treatment, EgTSP1 expression was significantly reduced in both stages of E. granulosus as compared to irrelevant/unrelated dsRNA and untreated controls. Silencing expression of EgTSP1 in different stages of E. granulosus resulted in reduced viability and body contractions, inhibition of protoscoleces evagination and distinctive tegumental changes. Ultrastructural morphology of the strobilated worms treated with EgTSP1-specific dsRNA was indicative of the microtriches impairments and vacuolated tegument compared to the control helminths. Conclusions: Results of the present study suggest that EgTSP1 plays important structural roles in tegument configuration in E. granulosus. EgTSP1 is proved to be a potential target for the development of vaccines and RNAi-based drugs.
Objectives. Due to Albendazole’s relatively low efficacy and bioavailability, Echinococcosis has proven a challenge to manage successfully, with several studies investigating ways to improve the outcome, mainly showing mixed results. We, therefore, aimed to evaluate whether Sulfonated Graphene Oxide (S‐GO), as nanocarriers, could improve the mentioned outcome. Methods. Echinococcus protoscoleces were divided into four groups based on the agent they received, which comprised control, S‐GO, Albendazole, and Albendazole‐loaded S‐GO (S‐GO‐Albendazole). Then, the Bax and Bcl-2 gene expression levels and the number of surviving protoscoleces in each group were determined. Results. Bax gene expression increased by 121% in the 50 μg/ml concentration of the S‐GO‐Albendazole, while Bcl-2 gene expression decreased by 64%. Moreover, S‐GO‐Albendazole was approximately 18% more effective at neutralizing protoscoleces than Albendazole and 14% and 31% more effective at improving the expression of the mentioned genes, respectively (p < 0.05). In addition, the number of surviving protoscoleces after exposure to the mentioned concentration reduced by approximately 99%. Conclusions. S‐GO, despite not having significant lethality on protoscoleces, significantly increased the lethality of Albendazole and, therefore, is a suitable nanocarrier. However, we recommend conducting in vivo and clinical studies to more accurately determine this nanocomplex’s potential and side effects.
1 January 2026 in International Journal of Microbiology
Introduction: Cryptosporidium is a leading protozoan cause of diarrheal disease globally, posing a significant threat to immunocompromised individuals, including patients with hematologic malignancies. This study was aimed at finding out how common Cryptosporidium is, what species and genotypes are present, and what risk factors are linked to patients with leukemia and lymphoma in Birjand, South Khorasan. This region has not had this information available before. Methods: In this cross‐sectional study conducted in 2023, stool samples were collected from 55 patients with confirmed hematologic cancers at Iranmehr Hospital, Birjand. Samples were examined using microscopy (modified Ziehl–Neelsen stain), and all were subsequently analyzed using a nested PCR assay targeting the gp60 gene for species and subtype identification. Demographic and risk factor data were collected and analyzed for association with infection using Fisher′s exact test. Results: The overall prevalence of cryptosporidiosis was 3.6% (two out of 55 cases). One case was found in a patient with leukemia (one out of 34; 2.9%), and another in a patient with lymphoma (one out of 21; 4.8%). The difference in prevalence between these groups was not statistically significant. Molecular analysis identified all isolates as Cryptosporidium parvum . Sequencing revealed two zoonotic subtypes: IIaA in the lymphoma patient and IIdA in the leukemia patient. A statistically significant association was found between infection and contact with animals ( p = 0.004) and having a high‐risk occupation ( p = 0.03). Conclusion: As the first report in our study area, we identified a 3.6% prevalence of cryptosporidiosis among patients with hematologic malignancies in Birjand, with zoonotic C. parvum subtypes as the sole etiological agents. The results emphasize the significant role of zoonotic transmission in this population and indicate a critical need for tailored preventive counseling to mitigate exposure risks associated with potential animal reservoirs for these vulnerable patients.